Cargando…
Modulated expression of adhesion, migration and activation molecules may predict the degree of response in chronic lymphocytic leukemia patients treated with ibrutinib plus rituximab
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Fondazione Ferrata Storti
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094098/ https://www.ncbi.nlm.nih.gov/pubmed/33054124 http://dx.doi.org/10.3324/haematol.2020.262071 |
| _version_ | 1783687947233525760 |
|---|---|
| author | Peragine, Nadia De Propris, Maria Stefania Intoppa, Stefania Milani, Maria Laura Mariglia, Paola Mauro, Francesca Romana Raponi, Sara Soddu, Stefano Cuneo, Antonio Rigolin, Gian Matteo Del Giudice, Ilaria Foà, Robin Guarini, Anna |
| author_facet | Peragine, Nadia De Propris, Maria Stefania Intoppa, Stefania Milani, Maria Laura Mariglia, Paola Mauro, Francesca Romana Raponi, Sara Soddu, Stefano Cuneo, Antonio Rigolin, Gian Matteo Del Giudice, Ilaria Foà, Robin Guarini, Anna |
| author_sort | Peragine, Nadia |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8094098 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Fondazione Ferrata Storti |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-80940982021-05-06 Modulated expression of adhesion, migration and activation molecules may predict the degree of response in chronic lymphocytic leukemia patients treated with ibrutinib plus rituximab Peragine, Nadia De Propris, Maria Stefania Intoppa, Stefania Milani, Maria Laura Mariglia, Paola Mauro, Francesca Romana Raponi, Sara Soddu, Stefano Cuneo, Antonio Rigolin, Gian Matteo Del Giudice, Ilaria Foà, Robin Guarini, Anna Haematologica Letters to the Editor Fondazione Ferrata Storti 2020-10-05 /pmc/articles/PMC8094098/ /pubmed/33054124 http://dx.doi.org/10.3324/haematol.2020.262071 Text en Copyright© 2021 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
| spellingShingle | Letters to the Editor Peragine, Nadia De Propris, Maria Stefania Intoppa, Stefania Milani, Maria Laura Mariglia, Paola Mauro, Francesca Romana Raponi, Sara Soddu, Stefano Cuneo, Antonio Rigolin, Gian Matteo Del Giudice, Ilaria Foà, Robin Guarini, Anna Modulated expression of adhesion, migration and activation molecules may predict the degree of response in chronic lymphocytic leukemia patients treated with ibrutinib plus rituximab |
| title | Modulated expression of adhesion, migration and activation molecules may predict the degree of response in chronic lymphocytic leukemia patients treated with ibrutinib plus rituximab |
| title_full | Modulated expression of adhesion, migration and activation molecules may predict the degree of response in chronic lymphocytic leukemia patients treated with ibrutinib plus rituximab |
| title_fullStr | Modulated expression of adhesion, migration and activation molecules may predict the degree of response in chronic lymphocytic leukemia patients treated with ibrutinib plus rituximab |
| title_full_unstemmed | Modulated expression of adhesion, migration and activation molecules may predict the degree of response in chronic lymphocytic leukemia patients treated with ibrutinib plus rituximab |
| title_short | Modulated expression of adhesion, migration and activation molecules may predict the degree of response in chronic lymphocytic leukemia patients treated with ibrutinib plus rituximab |
| title_sort | modulated expression of adhesion, migration and activation molecules may predict the degree of response in chronic lymphocytic leukemia patients treated with ibrutinib plus rituximab |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094098/ https://www.ncbi.nlm.nih.gov/pubmed/33054124 http://dx.doi.org/10.3324/haematol.2020.262071 |
| work_keys_str_mv | AT peraginenadia modulatedexpressionofadhesionmigrationandactivationmoleculesmaypredictthedegreeofresponseinchroniclymphocyticleukemiapatientstreatedwithibrutinibplusrituximab AT deproprismariastefania modulatedexpressionofadhesionmigrationandactivationmoleculesmaypredictthedegreeofresponseinchroniclymphocyticleukemiapatientstreatedwithibrutinibplusrituximab AT intoppastefania modulatedexpressionofadhesionmigrationandactivationmoleculesmaypredictthedegreeofresponseinchroniclymphocyticleukemiapatientstreatedwithibrutinibplusrituximab AT milanimarialaura modulatedexpressionofadhesionmigrationandactivationmoleculesmaypredictthedegreeofresponseinchroniclymphocyticleukemiapatientstreatedwithibrutinibplusrituximab AT marigliapaola modulatedexpressionofadhesionmigrationandactivationmoleculesmaypredictthedegreeofresponseinchroniclymphocyticleukemiapatientstreatedwithibrutinibplusrituximab AT maurofrancescaromana modulatedexpressionofadhesionmigrationandactivationmoleculesmaypredictthedegreeofresponseinchroniclymphocyticleukemiapatientstreatedwithibrutinibplusrituximab AT raponisara modulatedexpressionofadhesionmigrationandactivationmoleculesmaypredictthedegreeofresponseinchroniclymphocyticleukemiapatientstreatedwithibrutinibplusrituximab AT soddustefano modulatedexpressionofadhesionmigrationandactivationmoleculesmaypredictthedegreeofresponseinchroniclymphocyticleukemiapatientstreatedwithibrutinibplusrituximab AT cuneoantonio modulatedexpressionofadhesionmigrationandactivationmoleculesmaypredictthedegreeofresponseinchroniclymphocyticleukemiapatientstreatedwithibrutinibplusrituximab AT rigolingianmatteo modulatedexpressionofadhesionmigrationandactivationmoleculesmaypredictthedegreeofresponseinchroniclymphocyticleukemiapatientstreatedwithibrutinibplusrituximab AT delgiudiceilaria modulatedexpressionofadhesionmigrationandactivationmoleculesmaypredictthedegreeofresponseinchroniclymphocyticleukemiapatientstreatedwithibrutinibplusrituximab AT foarobin modulatedexpressionofadhesionmigrationandactivationmoleculesmaypredictthedegreeofresponseinchroniclymphocyticleukemiapatientstreatedwithibrutinibplusrituximab AT guarinianna modulatedexpressionofadhesionmigrationandactivationmoleculesmaypredictthedegreeofresponseinchroniclymphocyticleukemiapatientstreatedwithibrutinibplusrituximab |